Retina

Consultant ophthalmic surgeon Timothy L. Jackson, PhD FRCOphth reviews 3-year safety data of stereotactic radiotherapy for the treatment for wet AMD

Time-elapsed clinical images demonstrating the treatment results and impact of Oraya Therapy on wet AMD

Time-elapsed clinical images demonstrating the treatment results and impact of Oraya Therapy on wet AMD

Time-elapsed clinical images demonstrating the treatment results and impact of Oraya Therapy on wet AMD

Time-elapsed clinical images demonstrating the treatment results and impact of Oraya Therapy on wet AMD

“In Conversation With...”, an ongoing series of informal interviews with some of the biggest personalities in ophthalmology in glorious settings around the globe.

Five Things We Learned This Month

The Greek bailouts came with a price: austerity. This might come to pass as a highly myopic move. We explore its impact on ophthalmology – and the future health economic toll it will take on Greek society.

Adopting a treat-and-extend approach for the treatment of wet AMD with anti-VEGF drugs – though potentially complex in the coordination – can have considerable benefits for patients, carers and healthcare systems

Sitting down with... Anneke den Hollander, Professor, Department of Ophthalmology, Radboud University Medical Center, Nijmegen, the Netherlands